MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-01-0014788
Neomac Pharmaceuticals Private Limited
Neomac Pharmaceuticals Private Limited - pharma in Amritsar, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.43 Cr
▲ 21% YoY
Net profit · FY 2024
₹20.39 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹57.4 Lakh
EBITDA margin 6.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
49
Provident fund records
Directors on board
4
As per MCA filings
About Neomac Pharmaceuticals Private Limited
Data last updated:
Neomac Pharmaceuticals Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2015PTC039375. Its GSTIN is 03AAECN8999A1ZB (Punjab). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Naresh Mahajan and Mohd Yaqub Mir.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Second Floor 12 – Preet Vihar Circular Road Opp. Lakhanpal Axran, Amritsar, Punjab, India – 143001.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.43 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹20.39 Lakh (net margin 2.4%) and EBITDA of ₹57.4 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 24% over five years.
The company has about 49 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company.
Neomac Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-01-0014788). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232PB2015PTC039375
Registration Number 039375
Incorporation Date 10 April 2015
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-01-0014788
Recognitions & Rankings of Neomac Pharmaceuticals
Contact details
Neomac Pharmaceuticals Private Limited's registered office is in Amritsar, Punjab. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSecond Floor 12 – Preet Vihar Circular Road Opp. Lakhanpal Axran, Amritsar, Punjab, India – 143001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neomac Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neomac Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neomac Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neomac Pharmaceuticals Private Limited, buy the company report.
Financials of Neomac Pharmaceuticals Private Limited
FY 2025 filings availableNeomac Pharmaceuticals Private Limited reported revenue of ₹8.43 Cr (up 21% YoY) for FY 2024.
Revenue · FY 2024
₹8.43 Cr ▲ 21%
Net profit · FY 2024
₹20.39 Lakh margin 2.4%
EBITDA · FY 2024
₹57.4 Lakh margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 36%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 38%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 21% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neomac Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neomac Pharmaceuticals Private Limited
Neomac Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Mahajan Also directs: Salutemlab Formulations Private Limited, Salutemlife Sciences Private Limited, Polycoatt Films Private Limited and 5 more | Director | 10 Apr 2015 | 11 Years 6 Months | Current |
| Mohd Yaqub Mir | Director | 10 Apr 2015 | 11 Years 6 Months | Current |
| Shabir Ahmad Bhat | Director | 10 Apr 2015 | 11 Years 6 Months | Current |
| Sahil Mahajan Also directs: Salutemlab Formulations Private Limited, Salutemlife Sciences Private Limited, Polycoatt Films Private Limited and 5 more | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
Peer comparison
Neomac Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rancom Healthcare Private Limited | ₹8.47 Cr (FY 2021) | -8.0% | Lucknow, Uttar Pradesh, India | |||
| Aggarwal Medical Store Private Limited | ₹8.44 Cr (FY 2024) | -1.0% | New Delhi, Delhi, India | |||
| Alaric Healthcare Private Limited | ₹8.44 Cr (FY 2017) | 116.0% | Yamuna Nagar, Haryana, India | |||
| Neomac Pharmaceuticals Private Limitedthis company | ₹8.43 Cr (FY 2024) | ₹20.39 Lakh | 2.4% | 21.0% | 49 | Amritsar, Punjab, India |
| Litex Pharmaceuticals Private Limited | ₹8.43 Cr (FY 2024) | 18.0% | Delhi, India | |||
| Watran Pharmaceuticals Private Limited | ₹8.42 Cr (FY 2025) | 24.0% | Ambala, Haryana, India | |||
| Hindustan Trust Private Limited | ₹8.42 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Herbs and Health Makers (India) Private Limited | ₹8.38 Cr (FY 2025) | 1.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Neomac Pharmaceuticals Private Limited, buy the company report.
Auditor
Neomac Pharmaceuticals Private Limited is audited by SANJEEV ARORA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJEEV ARORA & CO. | FY 2017 | 014451N |
Shareholding
The shareholding of Neomac Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Neomac Pharmaceuticals Private Limited, buy the company report.
Legal cases
Neomac Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Neomac Pharmaceuticals. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Amritsar, Punjab | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Neomac Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neomac Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Neomac Pharmaceuticals Private Limited has a workforce of 49 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
49
Active EPFO establishments
1
Employee growth
13.95%
GST
Neomac Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAECN8999A1ZB | Punjab | Active | 01 Jul 2017 |
| 01AAECN8999A1ZF | Jammu and Kashmir | Active | 15 Jan 2022 |
To see the full GST registrations and return filing status of Neomac Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neomac Pharmaceuticals Private Limited has 6 board changes on record since 2015: 5 appointments and 1 cessation. The latest: Sahil Mahajan was appointed as Director on 28 Aug 2019.
AGM
Neomac Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Neomac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Sahil Mahajan was appointed as Director.
Ceased
Kavita Mahajan ceased to be Director.
Appointed
Kavita Mahajan was appointed as Director.
Appointed
Mohd Yaqub Mir was appointed as Director.
Appointed
Naresh Mahajan was appointed as Director.
Appointed
Shabir Ahmad Bhat was appointed as Director.
Incorporation
10 Apr 2015
Neomac Pharmaceuticals Private Limited was registered on 10 Apr 2015 with Roc Chandigarh & aged 11 years 6 months as per MCA records.
Frequently asked questions
Neomac Pharmaceuticals is an active private limited company based in Amritsar, Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 April 2015 (11+ years old) and is registered under CIN U24232PB2015PTC039375.
Neomac Pharmaceuticals has 4 current directors:
- Naresh Mahajan - Director
- Mohd Yaqub Mir - Director
- Shabir Ahmad Bhat - Director
- Sahil Mahajan - Director
The latest financial statements of Neomac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Neomac Pharmaceuticals is 03AAECN8999A1ZB, registered in Punjab. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 01AAECN8999A1ZF (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Neomac Pharmaceuticals is U24232PB2015PTC039375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neomac Pharmaceuticals has 1 court case on record: 1 filed by the company.
Neomac Pharmaceuticals was incorporated on 10 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Neomac Pharmaceuticals by revenue are Rancom Healthcare Private Limited, Aggarwal Medical Store Private Limited, Alaric Healthcare Private Limited, Litex Pharmaceuticals Private Limited, Watran Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sahil Mahajan was appointed as Director on 28 Aug 2019. Kavita Mahajan ceased to be Director on 31 Jul 2015. Kavita Mahajan was appointed as Director on 10 Apr 2015. Neomac Pharmaceuticals has 6 board changes on record in total.
Yes, Neomac Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-PB-01-0014788).
The registered office of Neomac Pharmaceuticals is at Second Floor 12 – Preet Vihar Circular Road Opp. Lakhanpal Axran, Amritsar, Punjab, India – 143001.